| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.2M | -5.8% |
| Cost of Revenue | $27.8M | -6.7% |
| Gross Profit | $28.4M | -4.8% |
| R&D Expense | $15.6M | -38.9% |
| SG&A Expense | $38.5M | -28.2% |
| Operating Income | -$39.4M | +48.6% |
| Pre-tax Income | -$33.3M | +54.0% |
| Income Tax | -$66K | +76.6% |
| Net Income | $19.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.5M | +60.1% |
| Short-term Investments | $42.5M | +66.0% |
| Accounts Receivable | $11.3M | -10.3% |
| Inventory | $13.0M | -19.7% |
| Current Assets | $144.6M | +40.3% |
| Total Assets | $190.1M | +19.2% |
| Current Liabilities | $34.1M | +35.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | +21.7% |
| Capital Expenditures | $955K | +58.6% |
| Investing Cash Flow | $50.7M | +209.6% |
| Financing Cash Flow | -$697K | -85.4% |
| Free Cash Flow | -$24.6M | +20.1% |
| +127.0% |
| EPS (Basic) | $0.54 | +125.5% |
| EPS (Diluted) | $0.54 | +125.5% |
| Total Liabilities |
| $46.4M |
| +3.3% |
| Stockholders' Equity | $143.7M | +25.4% |